We connect University startups with support and funding to turn their new idea or innovation into a commercial reality.
With our investment partners, Tanarra Capital and Breakthrough Victoria, the University supports access to investment and funding options for startups. These partnerships provide important financial support and access to commercial advice for entrepreneurial researchers, students and alumni as you navigate key stages of commercialisation through entrepreneurial endeavour.
UoM and Breakthrough Victoria's Genesis Pre-Seed Fund
The University of Melbourne and Breakthrough Victoria's Genesis Pre-Seed Fund backs early-stage startups with high potential. It supports researchers, students, alumni and innovators from affiliated organisations to take their innovation to a point where their startup is attractive to seed funding partners.
Breakthrough Victoria, an independent Victorian Government-owned company, is the University’s equal partner and co-investor in the UoM Genesis Pre-Seed Fund.
Tin Alley Ventures
The Tin Alley Ventures fund backs investment-ready, university-affiliated startups from seed stage through to exit. It provides access to investment, expertise and networks to help startups grow and secure faster, more successful exits.
The Fund helps startups grow their team, develop commercial grade products or services, target customers and provide access to global networks that can take a startup to the next level.
It’s a joint venture with the University run by investment firm, Tanarra Capital, with funding raised predominantly from external investors.
The Fund will be open to researchers, staff, students, alumni and University-affiliated organisations, including medical research institutes and hospital partners.
BioCurate identifies promising biomedical research discoveries of potential value to the bio-pharmaceutical sector.
Uniseed helps researchers from our partner research organisations, including the University, turn their ideas into products and services.
Other University-related investment funds
The University also has relationships with the following investment funds.
IP Group works with partner universities to develop deep technology research with commercial potential.
Brandon BioCatalyst transform biomedical research discoveries into new medical products.
Skalata aims help founders build the next generation of great companies.
Main Sequence Ventures
Main Sequence was founded by CSIRO to combine cutting edge scientific discoveries with the world's biggest challenges to build the next generation of global companies.